LCG 2288/08

• Research type

  Research Study

• Full title

  LCG 2288/08: A Phase I, single ascending dose, randomised, double blind, placebo-controlled study in healthy volunteers to investigate safety, tolerability, pharmacokinetics and pharmacodynamics of ITF2984 adminstered by subcutaneous injections.

• Contact name

  Anthony Priestley

• Contact email

  anthony.priestley@lcg-bourn.co.uk

• Sponsor organisation

  Italfarmaco S. p. A.

• ISRCTN Number

  N/A

• Clinicaltrials.gov Identifier

  N/A

• REC name

  East of England - Cambridgeshire and Hertfordshire Research Ethics Committee

• REC reference

  WCPEC090

• Date of REC Opinion

  31 May 2009

• REC opinion

  Favourable Opinion